Cargando…

ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination

We experienced a case of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis after Moderna COVID-19 vaccination. An 82-year-old woman developed pyrexia and general malaise one month after her third booster vaccine, and the symptoms persisted. Blood testing revealed i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gen, Shiko, Iwai, Takanori, Ohnari, Sayuri, Nobe, Kanako, Ikeda, Naofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125765/ https://www.ncbi.nlm.nih.gov/pubmed/37101523 http://dx.doi.org/10.1155/2023/4906876

Ejemplares similares

ANCA glomerulonephritis after the Moderna COVID-19 vaccination
por: Sekar, Arjun, et al.
Publicado: (2021)

ANCA-associated vasculitis after COVID-19
por: Izci Duran, Tugba, et al.
Publicado: (2021)

ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine
por: Yadav, Rukesh, et al.
Publicado: (2022)

A Case of Neurosarcoidosis-Induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone Diagnosed with Neuroendoscopy
por: Gen, Shiko, et al.
Publicado: (2018)

ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2021)

ANCA-associated vasculitis following the CoronaVac vaccination
por: Ma, Yaohui, et al.
Publicado: (2022)

Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination
por: Ohmura, Shin-ichiro, et al.
Publicado: (2022)

ANCA vasculitis: A manifestation of Post-Covid-19 Syndrome
por: Morris, Desiree, et al.
Publicado: (2021)

Manifestations of Covid-19-associated ANCA-vasculitis
por: Lishchuk-Yakymovych, Khrystyna, et al.
Publicado: (2023)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
por: Kitamoto, Kazuhiro, et al.
Publicado: (2023)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

POS-851 MPO-ANCA ASSOCIATED VASCULITIS AFTER COVID-19
por: GARCIA-VEGA, A., et al.
Publicado: (2022)

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab
por: Bruchfeld, Annette, et al.
Publicado: (2021)

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
por: Eindhoven, Stefanie, et al.
Publicado: (2017)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
por: Takeda, Sayo, et al.
Publicado: (2019)

Familial clusters of ANCA small-vessel vasculitis
por: Gomes, Ana Marta, et al.
Publicado: (2009)

Anaphylaxis after Moderna COVID-19 vaccine
por: Mayfield, Jeremy, et al.
Publicado: (2021)

c-ANCA-associated vasculitis with predominant CNS demyelination after COVID-19
por: Thabet, F., et al.
Publicado: (2023)

COVID-19 vaccination precipitating de novo ANCA-associated vasculitis: clinical implications
por: Mai, Aaron Shengting, et al.
Publicado: (2022)

Increase in the number of new cases of ANCA-associated vasculitis in the COVID-19 vaccine era
por: Sato, Tomohito, et al.
Publicado: (2023)

Levamisole-Induced ANCA Vasculitis and Cutaneous Necrosis
por: Tichauer, Matthew, et al.
Publicado: (2014)

MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
por: Obata, Shota, et al.
Publicado: (2021)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

The impact of COVID-19 pandemic on patients with ANCA associated vasculitis
por: Kant, Sam, et al.
Publicado: (2020)

De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19
por: Uppal, Nupur N., et al.
Publicado: (2020)

ANCA Vasculitis Induction Management During the COVID-19 Pandemic
por: Salas, Antonio, et al.
Publicado: (2021)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Methimazole-Induced ANCA Vasculitis: A Case Report
por: Neves, Precil Diego Miranda de Menezes, et al.
Publicado: (2021)

AZD-1222: ANCA-associated vasculitis: case report
Publicado: (2022)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
por: Khosla, Atulya Aman, et al.
Publicado: (2023)

A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
por: Al-Yafeai, Zaki, et al.
Publicado: (2022)

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
por: Kim, Beop Chang, et al.
Publicado: (2022)

Rat bite fever mimicking ANCA-associated vasculitis
por: Błaż, Aleksandra, et al.
Publicado: (2023)

Acute PR3-ANCA vasculitis in an asymptomatic COVID-19 teenager
por: Wintler, Taylor, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o4u8lngm0lfpdrl53cm6ge0vij